论美国生物育种安全法律制度
Safety Legal System of Biological Breeding Technology in the United States
DOI: 10.12677/ojls.2025.133067, PDF,    科研立项经费支持
作者: 张黄亦檬*, 郭渝丹:重庆工商大学法学与社会学学院,重庆
关键词: 生物育种技术安全性监管法律法规Biological Breeding Technology Safety Supervision Legislation and Regulations
摘要: 生物育种技术作为农业科技进步的重要驱动力,正处于快速发展的关键时期,如何保障生物育种技术的安全研发与应用成为难题。基于此,世界各国纷纷制定相应的法律法规进行监管。美国作为生物育种先驱国家,拥有较为完善的生物育种安全法律制度。与之相比,中国生物育种技术虽发展迅猛,但在安全法律规制方面仍面临不少挑战和问题。因此,吸收借鉴世界育种强国安全法律制度精华,为我国生物育种监管提供路径选择,显得紧迫而必要。本文从比较分析视角出发,聚焦于美国生物育种培育、审定及推广三个环节,通过分析考察美国政府在各环节中的制度设定及法律规定,从监管模式、产品审定和标识规定及激励制度四个方面,为我国生物育种安全管理模式提出改进建议。
Abstract: Biological breeding technology is an important driving force for the advancement of agriculture, and it is currently in a critical period of rapid development. How to ensure the safety of biological breeding technology research and application has become a difficult problem. Under this background, various countries around the world have successively formulated laws and regulations for supervision. As a pioneer in biological breeding technology around the world, the United States has a better safety legal system for the biological breeding technology. Compared with the United States, the biological breeding industry in China has developed at a faster pace, but there are still many challenges and problems in the safety legal supervision system. Therefore, it is urgent and necessary to draw on the essence of advanced legal supervision experience to provide the selection for the supervision of biological breeding technology in China. From the perspective of comparative analysis, this paper focuses on the cultivation, examination and promotion to analyze the legislation and regulations in all aspects of biological breeding technology in the United States. And then it puts forward suggestions to improve the safety supervision of biological breeding technology in China from four dimensions: supervision mode, examination process, labeling regulation and incentive system.
文章引用:张黄亦檬, 郭渝丹. 论美国生物育种安全法律制度[J]. 法学, 2025, 13(3): 466-474. https://doi.org/10.12677/ojls.2025.133067

参考文献

[1] 秦天宝. 欧盟生物技术产业发展的法律保障——以转基因生物安全管制为例的考察[J]. 河南财经政法大学学报, 2013, 28(4): 43-50.
[2] 周伟. 中美转基因安全管理工作对比分析——兼论新时期我国转基因安全管理改进策略[J]. 安徽农学通报, 2018, 24(8): 11-14.
[3] 唐勇. 不同国家转基因生物法律法规对生物育种产业的影响比较分析[J]. 分子植物育种, 2024, 22(4): 1164-1169.
[4] 刘世利. CRISPR基因编辑技术[M]. 北京: 化学工业出版社, 2020.
[5] Gupta, S., Kumar, A., Patel, R. and Kumar, V. (2021) Genetically Modified Crop Regulations: Scope and Opportunity Using the Crispr-Cas9 Genome Editing Approach. Molecular Biology Reports, 48, 4851-4863. [Google Scholar] [CrossRef] [PubMed]
[6] USDA Biotechnology Regulatory Services (2013) Minimum Separation Distances to Be Used for Confined Field Tests of Certain Genetically Engineered Plants.
[7] Wong, A.Y. and Chan, A.W. (2016) Genetically Modified Foods in China and the United States: A Primer of Regulation and Intellectual Property Protection. Food Science and Human Wellness, 5, 124-140. [Google Scholar] [CrossRef
[8] 张忠民. 转基因生物安全法律制度研究[M]. 重庆: 重庆大学出版, 2022.
[9] 张忠民. 转基因食品法律规制研究[M]. 北京: 中国政法大学出版社, 2014.
[10] Marchant, G.E. and Cardineau, G.A. (2013) The Labeling Debate in the United States. GM Crops & Food, 4, 126-134. [Google Scholar] [CrossRef] [PubMed]
[11] 张忠民. 美国转基因食品标识制度法律剖析[J]. 社会科学家, 2007(6): 70-74.
[12] Mosier, S.L., Rimal, A. and Ruxton, M.M. (2020) A Song of Policy Incongruence: The Missing Choir of Consumer Preferences in GMO‐Labeling Policy Outcomes. Review of Policy Research, 37, 511-534. [Google Scholar] [CrossRef
[13] Woźniak-Gientka, E., Agata, T., Milica, P., Anna, B., Dennis, E., Nick, V., et al. (2022) Public Perception of Plant Gene Technologies Worldwide in the Light of Food Security. GM Crops & Food, 13, 218-241. [Google Scholar] [CrossRef] [PubMed]
[14] 刘旭霞, 张楠. 美国国家生物工程食品信息披露标准法案评析[J]. 中国生物工程杂志, 2016, 36(11): 131-138.
[15] 植木哲. 医疗法律学[M]. 冷罗生, 等, 译. 北京: 法律出版社, 2006.
[16] 谢曼娜. 生物育种技术面临的法规挑战解析: 生物创新与法律碰撞[J]. 分子植物育种, 2024, 22(1): 150-154.